Faheem Hasnain on stage at the Endpoints News / PharmCube #BIIS18 summit in Shanghai (Endpoints News)

November 16, 2020 08:18 AM EST

Faheem Hasnain is going back to running a biotech startup. And he has his work cut out for him

John Carroll

Editor & Founder

After founding Gossamer Bio $GOSS and handing the CEO’s reins to his longtime colleague and co-founder Sheila Gujrathi, biotech entrepreneur Faheem Hasnain is stepping back …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Faheem Hasnain is going back to running a biotech startup. And he has his work cut out for him

John Carroll

Editor & Founder

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Novo says its CB1 drug helped shed weight, but efficacy and safety questions remain

Why did Eli Lilly ask a patient on a compounded GLP-1 drug for their medical information?

Biotech VC firm outlines plans for $100M fund

You bet your life: After I was diagnosed with a rare cancer, I discovered how a small band of physician-scientists ...

FDA OKs the first-ever self-administered vaccine, for flu

Breaking down silos with a new quantitative approach to drug development

Fa­heem Has­nain is go­ing back to run­ning a biotech start­up. And he has his work cut out for him

Editor & Founder

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Faheem Hasnain is going back to running a biotech startup. And he has his work cut out for him